Medical Polyetheretherketone Market Expected to Reach Valuation of US$ 1158.26 Million by 2032 - Future Market Insights, Inc.

2022-08-26 21:37:59 By : Ms. Fandy Lee

The medical polyetheretherketone market in the United States is projected to rise rapidly during the projected period, owing to an increase in the number of healthcare institutions and medical device advances. The expanding population in the United States is predicted to raise the demand for spine implants, stents, heart valves, and knee and hip implants, which is likely to drive the use of medical-grade plastics even further

NEWARK, Del, Aug. 12, 2022 (GLOBE NEWSWIRE) -- The global medical polyetheretherketone market is expected to reach a market valuation of US$ 572.54 Million by 2022, accelerating with a moderate CAGR of 7.3% by 2022-2032. The medical polyetheretherketone market size is anticipated to be valued at about US$ 1158.26 Million by 2032 end.

Increased adoption of medical polyetheretherketone as a substitute for metals has boosted the medical polyetheretherketone market. Aluminium, carbon steel, bronze, stainless steel, brass, titanium, and magnesium are among the metals that medical polyetheretherketone has begun to replace in significant numbers.

Request a Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15360

As a result of rigorous environmental rules, automakers are compelled to increase fuel economy, decrease maintenance needs, and lower noise levels. As a result of these laws, the trend for lighter automobiles is being driven by automobile light-weighting. Polyetheretherketone is a substantial improvement over metals for decreasing pollutants and increasing fuel efficiency.

The demand for medical polyetheretherketone will not grow as fast as it could because it is more expensive than other medical-grade polymers. But these plastics can't replace medical polyetheretherketone because it is a high-performance polymer with better qualities like high flexural strength, resistance to impact, resistance to chemicals and heat, and compatibility with living organisms. Strict rules about medical devices also make it hard to use medical polyetheretherketone in medical devices and implants.

Over the projection period, the Asia-Pacific region's revenue is anticipated to increase by 8.7 per cent. With a medical polyetheretherketone market value of USD 36.17 million in APAC for medical polyetheretherketone in 2021, cardiovascular applications emerged as the leading category in the region. This is due to the sedentary lifestyles of the young and old in nations such as China and India.

To satisfy the rising demand for dental implants and dentures in the region, it is anticipated that the adoption of medical polyetheretherketone denture base material will increase. As a result, in the Asia-Pacific area, dental implants and fixtures are anticipated to increase at a 9.3 per cent CAGR over the projection period.

Medical polyetheretherketone is emerging as an eco-friendly alternative in a variety of applications. Compared to other polymers, such as ABS, polyester laminate, polyvinyl chloride, polystyrene, and polysulphone, its use results in lower carbon emissions. By providing exceptional corrosion resistance, PEEK extends the service life of the goods in which it is utilised. It can also operate at elevated temperatures for a longer duration than other polymers. It is one of the most adaptable products in terms of production design flexibility, resulting in minimal labour dependence. The substantial benefits are leading the demand for medical polyetheretherketone.

Request Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-15360 Key Takeaways from Market Study

In 2021, the spine implantation segment led the medical polyetheretherketone market and contributed for more than 30.0% of global revenue.

North America held the biggest medical polyetheretherketone market share in 2021, at over 40 percent, and is anticipated to experience substantial increase throughout the forecast period.

In Canada, sales of medical polyetheretherketone are anticipated to expand at a CAGR of around 7% during the coming year. Both the commercial and public sectors are making substantial investments in Canada's healthcare industry, which is fuelling research and development.

There are currently 54 million Americans over the age of 65, and this number is predicted to rise to 74 million by 2030. The elderly population, which requires the most comprehensive care, is growing even more fast. The region's substantial elderly population is also driving growth in the medical polyetheretherketone industry.

Due to a few regional players, the global demand for medical polyetheretherketone is consolidated. Important participants include Panjin Zhongrun High-Performance Polymers Co. Ltd., Victrex Plc., Jrlon Inc., and Quadrant EPP Surlon India Ltd.

Increasing overall applicability in a range of areas, such as medical, aerospace, and automotive, has led to the expansion of the industrial service provider market and thus also changing the medical polyetheretherketone market outlook. Prototype & Plastic Mold Co. Inc., Parkway Products Inc., A. Schulman AG, and Stern Sectors Inc. are among the key service providers that use the product for injection moulding and other uses in a variety of industries.

Numerous industries, including as healthcare, aerospace, electronics, packaging, and autos, are anticipated to gain from the expanding medical polyetheretherketone market. Medical industries are patenting polyetheretherketone-based end-use innovations in order to acquire a competitive advantage over rivals.

Global Medical Polyetheretherketone Market Key Players

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-15360

Medical Polyetheretherketone Market by Segmentation

  2.2. Market Definition / Scope / Limitations

      3.2.1. Demand in Optimistic Scenario

      3.2.2. Demand in Likely Scenario

      3.2.3. Demand in Conservative Scenario

  3.4. Product Life Cycle Analysis

Have a Look at Healthcare Domain Related Research Reports: 

Portable Medical Devices Market Size : The overall Portable Medical Devices market is projected to expand at a CAGR of 10.7% during the forecast period.

Wearable Medical Devices Market Trends : According to Future Market Insights (FMI), the global wearable medical devices market is expected to gain impetus from investments into the therapeutics and health & fitness sectors, expanding steadily at a CAGR of close to 7% through 2031.

Disposable Medical Sensors Market Outlook : The disposable medical sensors market is expected to grow at a CAGR of 8.1% over the forecast period, from USD 6.5 billion in 2021 to USD 9.4 billion in 2026.

Acetaminophen API Market Forecast : The global acetaminophen API market is valued at US$ 1,150.2 Million in 2022. is projected to exhibit growth at a CAGR of 3.4% between 2022 and 2032 totaling US$ 1,606. 86 Million by 2032.

Multiple Unit Pellet Systems Market Shares : The global multiple unit pellet systems (MUPS) market was valued at US$ 3.48 Bn in the year 2021, expanding at a CAGR of 3.5% to reach an ~US$ 5.07 Bn by the end of 2032.

Therapeutic Apheresis Market Type : The demand for therapeutic apheresis is estimated to rise at a CAGR of 6.8% during the forecast period. The global therapeutic apheresis market share is projected to be valued at US$ 2577.9 Mn in 2022 and is expected to reach US$ 5313 Mn by 2032.

Contact-Free Sleep Monitoring Systems Market Demand : The global contact-free sleep monitoring systems market is likely to be valued at US$ 92.2 Million in 2022.

Portable Bioprocessing Bioreactors Market Analysis : The portable bioprocessing bioreactors market, which is valued at US$ 1562.6 million as on 2022, is anticipated to be valued at US$ 6978.3 million by 2032

Atrial Appendage Occluder Market Technology : The global atrial appendage occluder market garnered a market value of US$ 854.6 Million in 2022

Protein Purification And Isolation Market Growth : The global protein purification and isolation market is expected to reach a market valuation of US$ 8.29 Billion by the year 2022, accelerating with a moderate CAGR of 10.6% by 2022-2032.

About Future Market Insights (FMI)  

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.  Contact: 

Future Market Insights Inc.   Christiana Corporate, 200 Continental Drive,  Suite 401, Newark, Delaware - 19713, USA   T: +1-845-579-5705   Report: https://www.futuremarketinsights.com/reports/medical-polyetheretherketone-market For Sales Enquiries: sales@futuremarketinsights.com   Browse all Reports: https://www.futuremarketinsights.com/reports LinkedIn| Twitter| Blogs

Federated Hermes Chief Equity Strategist Phil Orlando joins Yahoo Finance Live to discuss Jerome Powell's latest comments and what the next steps from the Fed may be to fight inflation.

Yahoo Finance's Ines Ferre breaks down Friday's market action, with stocks closing at the lows of the session and the U.S. dollar rising.

The Fed chair obviously chose to ignore data released just today that shows that current consumer level inflation is not exactly out of control.

Though signs point to prices moderating, Powell said on Friday that the bank will continue to hike interest rates this year

Altria Group (MO) declares a dividend hike of 4.4%, taking its quarterly dividend to 94 cents per share. The company is focused on boosting shareholders' returns.

Follow Buffett’s lead. And collect big dividends while you’re at it.

Nio (NYSE: NIO) investors got some good news from Chinese authorities for the second day in a row today. The company's American depositary shares are responding again this morning, jumping 6% at the market open but easing to a gain of 1.9% as of 10:05 a.m. ET. Shares of the Chinese EV company spiked yesterday on news that the Chinese government was adding a new stimulus package to jump-start a sagging economy.

Yahoo Finance reporter Ines Ferre looks at how the stock market is reacting to Fed Chair Powell's speech at the Jackson Economic Hole Symposium.

The chip maker has lost a third of its value in 2022. Its CEO just made his biggest buy of shares since becoming CEO early last year.

The old stock market axiom to buy when others are fearful could readily apply right now, according to Ashish Shah, chief investment officer at Goldman Sachs. Amid concerns markets will be volatile following Federal Reserve Chair Jerome Powell’s Jackson Hole policy speech on Friday, Shah thinks that doesn’t mean investors should stay on the sidelines at present. It's preferable to buy "when there's fear in the market," say Shah. "Don't fall into the trap of buying when there's FOMO," he added. Ag

U.S. stocks close with big losses Friday after Federal Reserve Chair Jerome Powell said the central bank will continue its inflation battle until it falls back to around 2%.

In this article, we will be taking a look at the 10 energy stocks to buy before winter. To skip our detailed analysis of the energy sector and the prospective future demand for these stocks, you can go directly to see the 5 Energy Stocks to Buy Before Winter. In February 2022, the Russian Federation invaded […]

Canadian cannabis stocks are under pressure yet again today. As of 1:12 p.m. ET Friday, Tilray (NASDAQ: TLRY) stock was down by 5.4%, Canopy Growth's (NASDAQ: CGC) equity was in the red by 7.3%, and Aurora Cannabis' (NASDAQ: ACB) shares were lower by 7%. Yesterday, Democratic Sen. Ron Wyden admitted in comments to public policy magazine The American Prospect that the Cannabis Administration and Opportunity Act (CAOA) is unlikely to have the 60 votes required to pass.

Here's why one Wall Street analyst really loves Peloton's stock.

The news is good for some — but not for others.

Yahoo Finance Live anchors discuss EA stock performance after reports of an Amazon acquisition surface.

Shares of several fintech stocks lost ground today, along with the broader market, after Federal Reserve Chairman Jerome Powell indicated the Fed will stay hawkish until it sees further proof that inflation is coming down. Shares of the digital bank SoFi Technologies (NASDAQ: SOFI) fell roughly 7.6% today, while shares of artificial intelligence lender Upstart Holdings (NASDAQ: UPST) fell 10.3%, and shares of the large mortgage originator Rocket Companies (NYSE: RKT) ended the day down nearly 10.8%. The market waited all week for Powell to take the floor at the Fed's annual Jackson Hole Economic Symposium, looking for clarity on where the Fed might be headed with future interest rate hikes.

Yahoo Finance's Jared Blikre joins the Live show to discuss how stocks are moving in intraday trading after Fed Chair Powell's Jackson Hole speech.

Beijing offered a rare concession Friday, agreeing to allow U.S. accounting regulators to examine the audits of Chinese firms listed on American stock exchanges.

U.S. stocks plunged in a steep sell-off Friday after Federal Reserve Chair Jerome Powell reiterated the central bank's commitment to fight inflation in a hawkish speech at the Jackson Hole economic symposium.